Related Experiment Video
Updated: Oct 21, 2025

07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.4K
Clinical Impact of the Predict Prostate Risk Communication Tool in Men Newly Diagnosed with Nonmetastatic Prostate
David Thurtle1, Val Jenkins2, Alex Freeman3
1Department of Surgery, University of Cambridge School of Clinical Medicine, Cambridge, UK.
European Urology
|September 8, 2021
Summary
The Predict Prostate tool significantly reduces decisional conflict and uncertainty for men with nonmetastatic prostate cancer. This personalized risk communication improves prognosis perception, aiding informed treatment decisions.
Area of Science:
- Urology
- Medical Informatics
- Patient Decision Making
Background:
- Predict Prostate is a validated online tool for personalized risk communication in nonmetastatic prostate cancer.
- Its clinical impact on patient decision-making has not been previously assessed.
Purpose of the Study:
- To evaluate the effect of the Predict Prostate tool on patient decision-making and disease perception.
- To assess its impact on decisional conflict, uncertainty, anxiety, and survival perception.
Main Methods:
- A multicenter randomized controlled trial involving 145 men with newly diagnosed nonmetastatic prostate cancer.
- Participants were randomized to standard of care (SOC) or SOC plus the Predict Prostate tool.
- Outcomes were assessed using validated questionnaires on decisional conflict, uncertainty, anxiety, and survival perception.
Main Results:
- The Predict Prostate group showed a 26% reduction in decisional conflict scores (p=0.027).
- Patients using the tool had more accurate and realistic perceptions of survival outcomes (p<0.001).
- Over 90% of users found the tool useful and would recommend it.
Conclusions:
- Predict Prostate effectively reduces decisional conflict and uncertainty in prostate cancer patients.
- The tool fosters more realistic patient perceptions of prognosis and treatment impact.
- It serves as a valuable aid in the complex decision-making process for prostate cancer treatment.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
206
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
206
Cancer Survival Analysis
481
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
481

